Amruta Samant

Harvard University

H指数:3

被引数:66

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

ATM deficiency confers specific therapeutic vulnerabilities in bladder cancer

SCIENCE ADVANCES

IF12.5

2023-11-243

OAAI

MAPK pathway alterations are a targetable vulnerability in bladder cancer

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Identification of a Synthetic Lethal Relationship between Nucleotide Excision Repair Deficiency and Irofulven Sensitivity in Urothelial Cancer

CLINICAL CANCER RESEARCH

IF10.2

2020-11-1825

OAAI

Borcsok, Judit; Sztupinszki, Zsofia; Bekele, Raie; Gao, Sizhi P.; Diossy, Miklos; Samant, Amruta S.; Dillon, Kasia M.; Tisza, Viktoria; Spisak, Sandor; Rusz, Orsolya; Csabai, Istvan; Pappot, Helle; Frazier, Zoe J.; Konieczkowski, David J.; Liu, David; Vasani, Naresh; Rodrigues, James A.; Solit, David B.; Hoffman-Censits, Jean H.; Plimack, Elizabeth R.; Rosenberg, Jonathan E.; Lazaro, Jean-Bernard; Taplin, Mary-Ellen; Iyer, Gopa; Brunak, Soren; Lozsa, Rita; Van Allen, Eliezer M.; Szuts, David; Mouw, Kent W.; Szallasi, Zoltan

Palbociclib synergistically enhances the anticancer activity of cisplatin in P53 mutant model of upper gastrointestinal cancers

CANCER RESEARCH

IF16.6

2018-07-010

PRE

Design, synthesis, selection, and evaluation of a potent multi-kinase targeting N4-phenylsubstituted-7H-pyrrolo[2,3-d]pyrimidin-4-amine derivative with significant anticancer activity in P53 mutant and wild type models of upper gastrointestinal cancers

CANCER RESEARCH

IF16.6

2018-07-010

PRE

RS-41, a multi-targeted kinase inhibitor, induces cell cycle arrest and apoptosis in p53 mutant and wild type models of upper gastrointestinal cancers

CANCER RESEARCH